SOURCE: Lipomics Technologies Inc.

February 27, 2007 09:00 ET

Lipomics Technologies to Partner With UC Davis in Personalized Medicine Research

Lipomics to Retain Diagnostic Rights in Collaboration

WEST SACRAMENTO, CA -- (MARKET WIRE) -- February 27, 2007 -- Lipomics Technologies, Inc., a privately held company that specializes in the analysis of lipid metabolites, announced today that it has entered into an agreement with The University of California, Davis to collaborate on research projects with an emphasis on personalized medicine.

Lipomics will retain certain rights to develop diagnostic applications based on the data from the studies. Lipomics seeks to partner with academic institutions and drug companies to advance its goal of developing diagnostic tests for metabolic diseases.

"This is a valuable collaboration as we pursue discovery of markers for health and disease. Understanding individual response is essential to understanding metabolic disease and approaches to therapy and preventative care. We look forward to working with one of the nation's premier research institutions," said Steve Watkins, president and chief scientific officer at Lipomics.

About Lipomics

Lipomics Technologies provides industry-leading metabolic assessments for drug research, clinical diagnostics and personalized medicine. The Company's proprietary analytical technologies generate comprehensive, accurate and quantitative profiles of lipid metabolites.

A broad range of bioinformatics and analytical tools map these profiles to the underlying biochemical pathways. Through these tools, Lipomics delivers deep and rich knowledge about biological and metabolic changes induced by disease, drug action, nutritional or lifestyle influences.

In partnership with pharmaceutical, biotechnology and nutrition companies, Lipomics uses its technologies to discover new diagnostic biomarkers, improve drug discovery, develop companion diagnostics and enable individualized health management.

More information about Lipomics can be found at www.lipomics.com.

Contact Information

  • EDITORIAL CONTACTS:

    Sarina Chohan
    (916) 371-7974
    Email Contact

    Agency Contact

    Doug Forsyth
    Alchymia Communications®
    (541) 482-8744
    Email Contact